KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	Risankizumab (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[4] 37, 96, 97, 271
2	Risankizumab (Genetical Recombination)	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 97
3	Risankizumab 10 mg/ml (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96
4	Risankizumab 180 mg SC (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96
5	Risankizumab 600 mg IV (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96
6	Risankizumab 90 mg/ml (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96
7	Risankizumab IV (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97
8	Risankizumab On-Body Injector (OBI) (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96
9	Risankizumab SC (Synonym: Risankizumab (genetical recombination) (JAN))	[1] Risankizumab	[1] D11052 (Name: Risankizumab (genetical recombination) (JAN))	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97